Queuse are long. Life is short. So why waste time waiting when you can pay someone to do it for you In Washington D.C. -- a city that struggles with more than its share of bureaucratic practices -- a small industry is emerging that will queue for you to get everything from a driver’s license to a seat in a congressional hearing.
Michael Dorsey, one of the pioneering" service expediters", began going to traffic courts for other people back in 1988. Today his fees start at $ 20 and can go into the thousands to plead individual cases at the Bureau of Traffic Adjudication( his former employer). Mr. Dorsey knows what properly written parking ticket looks like, and often gets fines invalidated on its failures in formality. His clients include congressmen and diplomats, as well as firms for which tickets are an occupational hazard, such as taxi operators and television broadcasters.
Service expediters are not universally loved. Non-tax income, like fines
A. The Taming of the Queue.
B. Controversy over New Businesses.
C. You Wait, I Wait, We All Wait.
D. The Bureaucratic Beast.
Multifunction superpills aren’t nearly as farfetched as they may sound. And reducing such serious risks to heart health as soaring cholesterol, diabetes, and high blood pressure potentially could save many lives and be highly lucrative for drug companies. A combo pill from Pfizer (PFE) of its hypertension drug Norvasc and cholesterol-lowering agent Lipitor "could have huge potential," says Shaojing Tong, analyst at Mehta Partners. "Offering two functions in one pill itself is a huge convenience."
If such pills catch on, they could generate significant revenues for drug companies. In Pfizer’s ease, the goal is to transfer as many qualified patients as possible to the combo pill. Norvasc’s patents expire in 2007, but Pfizer could avoid losing all its revenues from the drug at once if it were part of a superpill. Sena Lund, an analyst at Cathay Financial, sees Pfizer selling $4.2 billion worth of Norvasc-Lipitor by 2007. That would help
A. contrast different responses to combopills
B. explain Pfizer’s expectation of doctors’ support
C. illustrate doctors’ possible reception of combopills
D. stress the importance of patient compliance
| Technology is a two-edged sword. Rarely
is this as clear as it is in the realm of health care. Technology allows doctors
to test their patients for genetic defects--and then to turn around and spread
the results throughout the world via the Internet. For someone in need of
treatment, that’s good news. But for someone in search of a job or an insurance
policy ,it can be all bad. Last week a corollary (推论) was proposed to the patients’ bill of rights now before Congress: a right to medical privacy. Beginning in 2002 ,under rules set to become law in February ,patients would be able to decide the conditions under which their personal medical data could leak. They would be able to examine their records and make corrections. They could learn who else had seen the information. Improper use of records by a caregiver or insurer could result in both civil and cri A. Patients can benefit a lot from medical technology. B. People are suffering from misuse of medical technology. C. We should be aware of the danger brought by medical technology. D. Despite treatment improvement, technology can be harmful. [单项选择]容积大于50或直系2.5m以上的露天储罐，接地不得少于（）个。
A. 3 B. 2 C. 4 我来回答: 提交
|
